Artiva Biotherapeutics, Inc. · NASDAQ:ARTV
Aslan Fred sold 62,178 Artiva Biotherapeutics, Inc. shares (Form 4)
Traded Nov 2, 2026 · Filed Nov 3, 2026
On Nov 2, 2026, Aslan Fred (Director, Chief Executive Officer) sold 62,178 Artiva Biotherapeutics, Inc. shares at US$4.18 for US$260K, leaving 1,457,428 shares. Filed Nov 3, 2026 (Form 4).
- Sold
- 62,178 shares
- Price
- US$4.18
- Value
- US$260K
- Holding after
- 1,457,428 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Common Stock | Sale | 62,178 | US$4.18 | 1,457,428 | Direct |
Source
Download original · View original at SEC
Related
- Artiva Biotherapeutics, Inc.
- Aslan Fred
- Artiva Biotherapeutics, Inc. shareholders
- Form 4 · Aslan Fred · Nov 18, 2026
- Form 4 · Aslan Fred · Oct 7, 2026
- Form 4 · Aslan Fred · Oct 6, 2026
- Form 4 · Aslan Fred · Sep 15, 2026
- Form 4 · Aslan Fred · Sep 14, 2026
- Form 4 · Miralles Gines Diego · Nov 18, 2026
- Form 4 · Horan Christopher · Nov 18, 2026
- Form 4 · Bush Jennifer · Nov 18, 2026
- Form 4 · Banerjee Subhashis · Nov 18, 2026
- Form 4 · Horan Christopher · Nov 3, 2026